Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference

Core Insights - Zevra Therapeutics, Inc. is participating in Guggenheim's 2nd Annual Healthcare Innovation Conference on November 12, 2025, at 11:30 a.m. ET [1] - The company's executive leadership team will engage in a fireside discussion and will also be available for one-on-one meetings with registered attendees [2] - Zevra focuses on developing therapies for rare diseases with limited or no treatment options, aiming to provide life-changing therapeutics [3] Company Overview - Zevra Therapeutics is a commercial-stage company that combines science, data, and patient needs to create transformational therapies for rare diseases [3] - The company employs unique, data-driven development and commercialization strategies to address complex drug development challenges [3]